We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
Graham Corp
GHM
$802M
| $1.1M | ﹤0.01% |
+8,900
| New | +$883K |
2026 Q2
0 quarters
|
|
2127
First National Corp
FXNC
$273M
| $1.09M | ﹤0.01% |
36,349
+12,079
| +50% | +$342K |
2025 Q1
5 quarters
|
|
2128
Griffon
GFF
$4.42B
| $1.09M | ﹤0.01% |
+11,149
| New | +$973K |
2026 Q2
0 quarters
|
|
2129
GeoPark
GPRK
$723M
| $1.08M | ﹤0.01% |
118,817
-247,232
| -68% | -$2.41M |
2025 Q3
3 quarters
|
|
2130
AB InBev
BUD
$161B
| $1.08M | ﹤0.01% |
13,086
-169,015
| -93% | -$13.3M |
2023 Q4
10 quarters
|
|
2131
Sigma Lithium
SGML
$885M
| $1.08M | ﹤0.01% |
84,988
+4,825
| +6% | +$81.1K |
2026 Q1
1 quarter
|
|
2132
Bakkt Inc
BKKT
$216M
| $1.07M | ﹤0.01% |
137,583
+68,189
| +98% | +$611K |
2026 Q1
1 quarter
|
|
2133
Lincoln Electric
LECO
$14.1B
| $1.07M | ﹤0.01% |
+4,033
| New | +$1.06M |
2026 Q2
0 quarters
|
|
2134
Zymeworks
ZYME
$2.04B
| $1.07M | ﹤0.01% |
40,948
+8,725
| +27% | +$222K |
2026 Q1
1 quarter
|
|
2135
Holley
HLLY
$310M
| $1.07M | ﹤0.01% |
418,694
-349,014
| -45% | -$990K |
2025 Q3
3 quarters
|
|
2136
DELISTED
National Storage Affiliates Trust
NSA
| $1.07M | ﹤0.01% |
+24,000
| New | +$1.03M |
2026 Q2
0 quarters
|
|
2137
Apyx Medical
APYX
$103M
| $1.06M | ﹤0.01% |
236,466
+174,630
| +282% | +$692K |
2025 Q4
2 quarters
|
|
2138
Invesco S&P 500 Revenue ETF
RWL
$10.3B
| $1.06M | ﹤0.01% |
+8,307
| New | +$1.03M |
2026 Q2
0 quarters
|
|
2139
C4 Therapeutics
CCCC
$365M
| $1.06M | ﹤0.01% |
227,003
+71,508
| +46% | +$245K |
2025 Q3
3 quarters
|
|
|
OGG
2140
Osisko Gold Group
OGG
$777M
| $1.06M | ﹤0.01% |
+430,613
| New | +$1.28M |
2026 Q2
0 quarters
|
|
2141
Microbot Medical
MBOT
$63.3M
| $1.06M | ﹤0.01% |
541,963
+60,918
| +13% | +$124K |
2026 Q1
1 quarter
|
|
2142
Protalix BioTherapeutics
PLX
$200M
| $1.05M | ﹤0.01% |
+452,757
| New | +$959K |
2026 Q2
0 quarters
|
|
2143
Green Brick Partners
GRBK
$2.76B
| $1.05M | ﹤0.01% |
13,174
+3,663
| +39% | +$253K |
2024 Q1
9 quarters
|
|
2144
Future Fuel
FF
$252M
| $1.05M | ﹤0.01% |
232,306
-152,593
| -40% | -$658K |
2024 Q1
9 quarters
|
|
2145
Rice Acquisition Corporation 3
KRSP
$482M
| $1.05M | ﹤0.01% |
100,000
-53,491
| -35% | -$556K |
2026 Q1
1 quarter
|
|
2146
Barings BDC
BBDC
$869M
| $1.05M | ﹤0.01% |
+122,815
| New | +$1.05M |
2026 Q2
0 quarters
|
|
2147
Eupraxia Pharmaceuticals
EPRX
$452M
| $1.05M | ﹤0.01% |
158,133
| – | – |
2025 Q4
2 quarters
|
|
2148
Lazard International Dynamic Equity ETF
IDEQ
$1.69B
| $1.04M | ﹤0.01% |
+29,692
| New | +$1.02M |
2026 Q2
0 quarters
|
|
2149
LuxExperience B.V.
LUXE
$1.27B
| $1.04M | ﹤0.01% |
140,124
+13,923
| +11% | +$111K |
2026 Q1
1 quarter
|
|
2150
i3 Verticals
IIIV
$308M
| $1.04M | ﹤0.01% |
+48,713
| New | +$1.02M |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.